Cell therapy stocks
We cover 86 companies grouped under the Cell therapy theme. The median market value in the group is $57.47M. Across the group, the median move over the past trading day is +0.57%. 40% of the 84 with a 200-day average trade above it. Price change over the past year runs from −73.4% to +88.4% across the middle 80 percent of the group, with a median of −20.0%.
Other lists in this group
Daily Analysis
Aug 26, 2026Generated from today's data · Not investment adviceThe group contains 86 companies. The median market value is $57,474,732.5, meaning the company in the middle of the pack is about this size. The median one-day move is 0.6%. 40% of the 84 companies measured were trading above their own 200-day average, which is a stock's average price over its past 200 trading days.
Over the past year, results measured across all 86 companies ranged widely: the 10th percentile was -73.4%, meaning roughly one in ten companies was at or below that result, while the median was -20.0% and the 90th percentile was 88.4%. Among the listed largest members, one-year changes ranged from Legend Biotech Corporation (LEGN) at -38.4% to Iovance Biotherapeutics, Inc. (IOVA) at 233.6%.
Among mid caps, Iovance Biotherapeutics, Inc. (IOVA) had the widest one-year change at 233.6%. Among small caps, Immix Biopharma, Inc. (IMMX) had the widest one-year change at 589.1%, while Iovance Biotherapeutics, Inc. (0JDK.L) had the largest one-day move at 70.5%. Among micro caps, Chimeric Therapeutics Limited (CHM.AX) had the widest one-year change at -95.7%, and Longeveron Inc. (LGVN) had the largest one-day move at -18.9%.
Table
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| LEGN | Legend Biotech Corporation | $4.14B | Mid cap | −38.44% |
| IOVA | Iovance Biotherapeutics, Inc. | $3.82B | Mid cap | +233.60% |
| MSB.AX | Mesoblast Limited | $2.25B | Mid cap | −3.82% |
| MESO | Mesoblast Limited | $2.23B | Mid cap | +9.42% |
| VCEL | Vericel Corporation | $2.21B | Mid cap | +20.76% |
| BLFS | BioLife Solutions, Inc. | $1.82B | Small cap | +45.11% |
| VOR | Vor Biopharma Inc. | $1.30B | Small cap | −41.72% |
| SANA | Sana Biotechnology, Inc. | $1.23B | Small cap | +22.39% |
| IMMX | Immix Biopharma, Inc. | $968.90M | Small cap | +589.05% |
| SYNC.L | Syncona Limited | $923.83M | Small cap | +15.68% |
| CYRX | Cryoport, Inc. | $846.85M | Small cap | +89.78% |
| ALLO | Allogene Therapeutics, Inc. | $749.72M | Small cap | +87.07% |
| PROK | ProKidney Corp. | $690.59M | Small cap | −26.38% |
| AUTL | Autolus Therapeutics plc | $649.44M | Small cap | +52.50% |
| ARTV | Artiva Biotherapeutics, Inc. | $575.44M | Small cap | +317.38% |
| KYTX | Kyverna Therapeutics, Inc. | $546.70M | Small cap | +132.02% |
| CABA | Cabaletta Bio, Inc. | $545.94M | Small cap | +102.52% |
| 0JDK.L | Iovance Biotherapeutics, Inc. | $501.00M | Small cap | +248.46% |
| 4592.T | SanBio Company Limited | $495.75M | Small cap | −55.90% |
| CAPR | Capricor Therapeutics, Inc. | $481.97M | Small cap | +25.61% |
| 005690.KS | Pharmicell Co., Ltd. | $472.35M | Small cap | +1.56% |
| 0HX7.L | Adicet Bio, Inc. | $415.26M | Small cap | −24.75% |
| IPSC | Century Therapeutics, Inc. | $392.93M | Small cap | +324.66% |
| LYEL | Lyell Immunopharma, Inc. | $379.58M | Small cap | +41.20% |
| ALCLS.PA | Cellectis S.A. | $345.47M | Small cap | +19.05% |
| CLLS | Cellectis S.A. | $344.40M | Small cap | +27.14% |
| 219A.T | HEARTSEED INC | $338.82M | Small cap | −32.33% |
| FATE | Fate Therapeutics, Inc. Common Stock | $305.54M | Small cap | +133.94% |
| RNAC | Cartesian Therapeutics, Inc. | $304.37M | Small cap | −7.73% |
| 4894.T | Cuorips Inc. | $291.63M | Small cap | −19.00% |
| LCTX | Lineage Cell Therapeutics, Inc. | $275.67M | Small cap | −3.42% |
| 4593.T | Healios K.K. | $239.21M | Small cap | −40.92% |
| 7774.T | Japan Tissue Engineering Co., Ltd. | $223.27M | Small cap | +79.30% |
| NKTX | Nkarta, Inc. | $194.10M | Small cap | +23.18% |
| 504A.T | Innovacell Inc. | $156.32M | Small cap | −47.14% |
| OCC.AX | Orthocell Limited | $152.21M | Small cap | −35.00% |
| MXCT | MaxCyte, Inc. | $139.33M | Small cap | −2.88% |
| 0HIY.L | Atara Biotherapeutics, Inc. | $124.82M | Small cap | −20.36% |
| ATRA | Atara Biotherapeutics, Inc. | $98.77M | Micro cap | −19.61% |
| ACET | Adicet Bio, Inc. | $84.25M | Micro cap | −20.89% |
| INKT | MiNK Therapeutics, Inc. | $60.32M | Micro cap | −21.89% |
| V3V.DE | FamiCord AG | $58.21M | Micro cap | −60.69% |
| 7776.T | CellSeed Inc. | $56.74M | Micro cap | −47.42% |
| 4896.T | K Pharma,Inc. | $56.45M | Micro cap | +15.89% |
| 4584.T | Kidswell Bio Corporation | $55.83M | Micro cap | −24.37% |
| HEMO.L | Hemogenyx Pharmaceuticals Plc | $53.78M | Micro cap | +81.25% |
| ALA.AX | Arovella Therapeutics Limited | $52.84M | Micro cap | −26.19% |
| ALPS | Alps Group Inc | $52.42M | Micro cap | −87.70% |
| TCRX | TScan Therapeutics, Inc. | $51.87M | Micro cap | −58.23% |
| 7096.T | StemCell Institute Inc. | $48.78M | Micro cap | −21.54% |
| TVGN | Tevogen Inc. | $44.34M | Micro cap | −84.85% |
| 2370.T | MEDINET Co., Ltd. | $44.25M | Micro cap | −34.21% |
| 3750.T | ADR Biomedical Holdings Inc. | $43.59M | Micro cap | −15.61% |
| 4880.T | CellSource Co., Ltd. | $43.15M | Micro cap | −41.78% |
| DTSQ | DT Cloud Star Acquisition Corporation | $41.39M | Micro cap | +8.42% |
| 4893.T | Noile-Immune Biotech Inc. | $40.36M | Micro cap | −17.32% |
| PTG.WA | Poltreg S.A. | $36.84M | Micro cap | −16.00% |
| 4892.T | Cyfuse Biomedical K.K. | $36.02M | Micro cap | −9.22% |
| CCEL | Cryo-Cell International, Inc. | $34.67M | Micro cap | −0.92% |
| ESLA | Estrella Immunopharma, Inc. | $31.97M | Micro cap | −24.41% |
| SVA.TO | Sernova Biotherapeutics Inc | $30.03M | Micro cap | −38.89% |
| PSH0.DE | Sernova Biotherapeutics Inc | $26.97M | Micro cap | −46.78% |
| 0NLV.L | FamiCord AG | $21.73M | Micro cap | −61.12% |
| LGVN | Longeveron Inc. | $21.68M | Micro cap | −12.71% |
| 311A.T | NPT Co Ltd | $20.81M | Micro cap | −43.33% |
| NCEL | NewcelX Ltd. | $19.83M | Micro cap | −85.80% |
| PLUR | Pluri Inc. | $17.91M | Micro cap | −71.43% |
| BCDA | BioCardia, Inc. | $17.11M | Micro cap | −42.05% |
| SNTI | Senti Biosciences Holdings, Inc. | $12.17M | Micro cap | −75.42% |
| F98.F | CytoMed Therapeutics Limited | $11.54M | Micro cap | −54.82% |
| INAB | IN8bio, Inc. | $11.53M | Micro cap | −46.58% |
| GDTC | CytoMed Therapeutics Limited | $11.06M | Micro cap | −52.59% |
| FBLG | FibroBiologics, Inc. | $9.32M | Micro cap | −88.54% |
| CMB.AX | Cambium Bio Limited | $8.86M | Micro cap | 0.00% |
| CELZ | Creative Medical Technology Holdings, Inc. | $7.98M | Micro cap | −61.19% |
| 1AD.AX | AdAlta Limited | $6.90M | Micro cap | −12.50% |
| ERNA | Ernexa Therapeutics Inc. | $5.87M | Micro cap | −86.22% |
| PMCB | PharmaCyte Biotech, Inc. | $5.79M | Micro cap | −48.78% |
| BRTX | BioRestorative Therapies, Inc. | $5.67M | Micro cap | −85.26% |
| 0QFK.L | Celyad Oncology SA | $4.54M | Micro cap | −16.07% |
| MBIO | Mustang Bio, Inc. | $4.18M | Micro cap | −64.16% |
| BSFA.L | BSF Enterprise Plc | $3.04M | Micro cap | −44.44% |
| CYP.AX | Cynata Therapeutics Limited | $1.92M | Micro cap | −94.88% |
| CHM.AX | Chimeric Therapeutics Limited | $659.83K | Micro cap | −95.67% |
| CRBU | Caribou Biosciences, Inc. | — | — | −6.38% |
| DTSQU | DT Cloud Star Acquisition Corporation | — | Small cap | +9.95% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.